MX2015014944A - Derivados de 3-(2-aminopiridin-4-il)-5-(3-hidroxipropinil)-1h-pirr olo[2,3-c]piridina como inhibidores de la nik para el tratamiento del cancer. - Google Patents

Derivados de 3-(2-aminopiridin-4-il)-5-(3-hidroxipropinil)-1h-pirr olo[2,3-c]piridina como inhibidores de la nik para el tratamiento del cancer.

Info

Publication number
MX2015014944A
MX2015014944A MX2015014944A MX2015014944A MX2015014944A MX 2015014944 A MX2015014944 A MX 2015014944A MX 2015014944 A MX2015014944 A MX 2015014944A MX 2015014944 A MX2015014944 A MX 2015014944A MX 2015014944 A MX2015014944 A MX 2015014944A
Authority
MX
Mexico
Prior art keywords
cancer
treatment
hydroxypropynyl
aminopyrimidin
pyrrolo
Prior art date
Application number
MX2015014944A
Other languages
English (en)
Other versions
MX369159B (es
Inventor
Stephen Price
John Gary Montana
Calum Macleod
George Hynd
Janusz Kulagowski
Samuel Edward Mann
Terry Aaron Panchal
Patrizia Tisselli
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MX2015014944A publication Critical patent/MX2015014944A/es
Publication of MX369159B publication Critical patent/MX369159B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se relaciona con compuestos de fórmula (I) que son inhibidores de la quinasa inductora del NF-B (NIK - que también conocida como MAP3K14) que son de utilidad para tratar enfermedades tales como el cáncer, los trastornos inflamatorios, los trastornos metabólicos y los trastornos autoinmunes; la invención también se refiere a composiciones farmacéuticas que comprenden dichos compuestos, a procesos para preparar dichos compuestos y composiciones y al uso de tales compuestos o composiciones farmacéuticas en la prevención o el tratamiento de enfermedades tales como el cáncer, los trastornos inflamatorios, los trastornos metabólicos que incluyen la obesidad y la diabetes, y los trastornos autoinmunes.
MX2015014944A 2013-04-24 2014-04-24 Derivados de 3-(2-aminopiridin-4-il)-5-(3-hidroxipropinil)-1h-pirr olo[2,3-c]piridina como inhibidores de la nik para el tratamiento del cancer. MX369159B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13165167 2013-04-24
EP13186116 2013-09-26
PCT/EP2014/058361 WO2014174021A1 (en) 2013-04-24 2014-04-24 3-(2-aminopyrimidin-4-yl)-5-(3-hydroxypropynyl)-1h-pyrrolo[2,3-c]pyridine derivatives as nik inhibitors for the treatment of cancer

Publications (2)

Publication Number Publication Date
MX2015014944A true MX2015014944A (es) 2016-03-07
MX369159B MX369159B (es) 2019-10-30

Family

ID=50543609

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015014944A MX369159B (es) 2013-04-24 2014-04-24 Derivados de 3-(2-aminopiridin-4-il)-5-(3-hidroxipropinil)-1h-pirr olo[2,3-c]piridina como inhibidores de la nik para el tratamiento del cancer.

Country Status (15)

Country Link
US (1) US9643964B2 (es)
EP (1) EP2989101B1 (es)
JP (1) JP6389511B2 (es)
KR (1) KR102336291B1 (es)
CN (1) CN105143223B (es)
AU (1) AU2014259477B2 (es)
BR (1) BR112015026721B1 (es)
CA (1) CA2907751C (es)
EA (1) EA029219B1 (es)
ES (1) ES2773138T3 (es)
HK (1) HK1215430A1 (es)
IL (1) IL242170B (es)
MX (1) MX369159B (es)
TW (1) TWI663166B (es)
WO (1) WO2014174021A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2016002238A (es) 2013-08-22 2016-05-31 Hoffmann La Roche Alcoholes de alquilino y metodos de uso.
TWI704146B (zh) * 2013-09-26 2020-09-11 比利時商健生藥品公司 用作ＮＩＫ抑制劑之新的1-(４-嘧啶基)-１Ｈ-吡唑並[３,２-ｃ]吡啶衍生物
TWI627173B (zh) * 2013-09-26 2018-06-21 比利時商健生藥品公司 作為ＮＩＫ抑制劑的新穎３－（１Ｈ－吡唑－４－基）－１Ｈ－吡咯并［２，３－ｃ］吡啶衍生物
DK3157916T3 (en) * 2014-06-19 2019-03-18 Ariad Pharma Inc HETEROARYL COMPOUNDS FOR CHINESE INHIBITION
US10323045B2 (en) 2014-10-23 2019-06-18 Janssen Pharmaceutica Nv Thienopyrimidine derivatives as NIK inhibitors
KR102523405B1 (ko) 2014-10-23 2023-04-18 얀센 파마슈티카 엔.브이. Ｎｉｋ 억제제로서의 신규 피라졸로피리미딘 유도체
KR102500071B1 (ko) * 2014-10-23 2023-02-14 얀센 파마슈티카 엔.브이. Ｎｉｋ 억제제로서의 신규 화합물
MX371150B (es) 2014-10-23 2020-01-20 Janssen Pharmaceutica Nv NUEVOS DERIVADOS DE PIRAZOL EN CALIDAD DE INHIBIDORES DE LA CINASA INDUCTORA DE NF-kB (NIK).
US10112924B2 (en) 2015-12-02 2018-10-30 Astraea Therapeutics, Inc. Piperdinyl nociceptin receptor compounds
AU2016365400C1 (en) * 2015-12-02 2022-11-10 Astraea Therapeutics, Llc Piperidinyl nociceptin receptor compounds
WO2017125534A1 (en) 2016-01-22 2017-07-27 Janssen Pharmaceutica Nv New 6-membered heteroaromatic substituted cyanoindoline derivatives as nik inhibitors
AU2017209935B2 (en) 2016-01-22 2021-04-01 Janssen Pharmaceutica Nv New substituted cyanoindoline derivatives as NIK inhibitors
CN109689645B (zh) * 2016-06-30 2022-06-03 杨森制药有限公司 作为nik抑制剂的氰基吲哚啉衍生物
EP3478675B1 (en) 2016-06-30 2020-04-22 Janssen Pharmaceutica NV Heteroaromatic derivatives as nik inhibitors
WO2018037058A1 (en) * 2016-08-24 2018-03-01 F. Hoffmann-La Roche Ag 2-azabicyclo[3.1.0]hexan-3-one derivatives and methods of use
JP7140751B2 (ja) 2016-08-24 2022-09-21 エフ．ホフマン－ラ ロシュ アーゲー ２－アザビシクロ［３．１．０］ヘキサン－３－オン誘導体及び使用方法
BR112021023796A2 (pt) 2019-05-31 2022-02-08 Janssen Pharmaceutica Nv Inibidores de moléculas pequenas de quinase indutora de nf-capab
CN113816957B (zh) * 2021-10-29 2023-04-07 浙江工业大学 4-(7-氮杂吲哚)-2-氨基嘧啶类化合物及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR056786A1 (es) 2005-11-10 2007-10-24 Smithkline Beecham Corp Compuesto de 1h- imidazo ( 4,5-c) piridin-2-ilo, composicion farmaceutica que lo comprende, procedimiento para preparar dicha composicion, su uso para preparar unmedicamento, uso de una combinacion que omprende al compuesto y al menos un agente antineoplasico para preparar un medicamento y dicha com
DE102008005493A1 (de) 2008-01-22 2009-07-23 Merck Patent Gmbh 4-(Pyrrolo[2,3-c] pyridine-3-yl)-pyrimidin-2-yl-amin-derivate
US20110086834A1 (en) * 2008-06-26 2011-04-14 Amgen Inc. Alkynyl alcohols as kinase inhibitors
US20110201599A1 (en) * 2008-07-03 2011-08-18 Exelixis, Inc. CDK Modulators
US20110183975A1 (en) * 2008-10-07 2011-07-28 Yasuhiro Goto Novel 6-azaindole aminopyrimidine derivatives having nik inhibitory activity
CN101723936B (zh) 2008-10-27 2014-01-15 上海睿星基因技术有限公司 激酶抑制剂及其在药学中的用途
WO2012123522A1 (en) 2011-03-16 2012-09-20 F. Hoffmann-La Roche Ag 6,5-heterocyclic propargylic alcohol compounds and uses therefor
TWI627173B (zh) 2013-09-26 2018-06-21 比利時商健生藥品公司 作為ＮＩＫ抑制劑的新穎３－（１Ｈ－吡唑－４－基）－１Ｈ－吡咯并［２，３－ｃ］吡啶衍生物
TWI704146B (zh) 2013-09-26 2020-09-11 比利時商健生藥品公司 用作ＮＩＫ抑制劑之新的1-(４-嘧啶基)-１Ｈ-吡唑並[３,２-ｃ]吡啶衍生物
MX371150B (es) 2014-10-23 2020-01-20 Janssen Pharmaceutica Nv NUEVOS DERIVADOS DE PIRAZOL EN CALIDAD DE INHIBIDORES DE LA CINASA INDUCTORA DE NF-kB (NIK).
KR102500071B1 (ko) 2014-10-23 2023-02-14 얀센 파마슈티카 엔.브이. Ｎｉｋ 억제제로서의 신규 화합물
KR102523405B1 (ko) 2014-10-23 2023-04-18 얀센 파마슈티카 엔.브이. Ｎｉｋ 억제제로서의 신규 피라졸로피리미딘 유도체
US10323045B2 (en) 2014-10-23 2019-06-18 Janssen Pharmaceutica Nv Thienopyrimidine derivatives as NIK inhibitors

Also Published As

Publication number Publication date
WO2014174021A1 (en) 2014-10-30
EA201592033A1 (ru) 2016-04-29
AU2014259477B2 (en) 2018-05-24
CA2907751C (en) 2021-04-20
CN105143223A (zh) 2015-12-09
CN105143223B (zh) 2018-11-30
KR102336291B1 (ko) 2021-12-07
EP2989101A1 (en) 2016-03-02
JP6389511B2 (ja) 2018-09-12
HK1215430A1 (zh) 2016-08-26
CA2907751A1 (en) 2014-10-30
MX369159B (es) 2019-10-30
US9643964B2 (en) 2017-05-09
JP2016517859A (ja) 2016-06-20
BR112015026721B1 (pt) 2022-07-19
EP2989101B1 (en) 2019-11-27
TWI663166B (zh) 2019-06-21
US20160075699A1 (en) 2016-03-17
BR112015026721A2 (pt) 2017-07-25
TW201534605A (zh) 2015-09-16
EA029219B1 (ru) 2018-02-28
KR20150144763A (ko) 2015-12-28
ES2773138T3 (es) 2020-07-09
IL242170B (en) 2020-08-31
AU2014259477A1 (en) 2015-10-01

Similar Documents

Publication Publication Date Title
MX2015014944A (es) Derivados de 3-(2-aminopiridin-4-il)-5-(3-hidroxipropinil)-1h-pirr olo[2,3-c]piridina como inhibidores de la nik para el tratamiento del cancer.
PH12018502125A1 (en) Bipyrazole derivatives as jak inhibitors
MX2016003863A (es) Nuevos derivados de 3-(1h-pirazol-4-il)-1h-pirrolo[2,3-c]piridina como inhibidores de la cinasa inductora de nf-kappab.
PH12018501567A1 (en) New substituted cyanoindoline derivatives as nik inhibitors
MX2016003861A (es) Nuevos derivados de 1-(4-pirimidinil)-1h-pirrolo[3,2-c]piridina como inhibidores de la cinasa inductora de nf-kappab.
EA033236B1 (ru) Новые производные пиразола в качестве ингибиторов nik
EA033343B1 (ru) Соединения, ингибирующие rip2-киназу, фармацевтическая композиция на их основе и их применение для лечения заболеваний, опосредуемых rip2-киназой
SG10201909545XA (en) Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
MX2017005285A (es) Nuevos derivados de tienopirimidina en calidad de inhibidores de la cinasa inductora de nf-kb (nik).
EA033237B1 (ru) Новые производные пиразолопиримидина в качестве ингибиторов nik, фармацевтическая композиция и лекарственное средство, содержащее ее
MX2017005282A (es) Nuevos compuestos como inhibidores de la cinasa inductora de nf-kb (nik).
MX2014000964A (es) Derivados aza heterociclicos sustituidos.
MX2019014665A (es) Nuevos derivados de azaindolina sustituida como inhibidores de nik.
MX366840B (es) Pirimidinas novedosas 2,5-sustituidas como inhibidores de pde.
MX2018007517A (es) Compuestos triciclicos y composiciones como inhibidores de quinasa.
MX2014003455A (es) Derivados de metanosulfonamida sustituidos con arilo o n-heteroarilo como ligandos de receptor vanilloide.
MX2014003584A (es) Derivados de metanosulfonamida sustituidos como ligandos de receptores vaniloides.
MX2017003016A (es) Derivados de piridazinona como inhibidores de las fosfoinositido-3-cinasas.
EA201891687A9 (ru) Новые замещённые производные цианиндолина в качестве nik-ингибиторов
MY192305A (en) Bipyrazole derivatives as jak inhibitors

Legal Events

Date Code Title Description
FG Grant or registration